RTX vs TMO · P/E 36, rev $88.60B vs P/E 24, rev $44.56B
RTX Corporation (RTX) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the RTX and TMO stock pages for the full models.
Not investment advice.